Table 4.

Antibacterial susceptibility profile of human milk Lactobacillus isolates to commercial antibiotics

S. no.	Antibiotics	HM1	HM2	HM3	HM6	HM7	HM8	HM9	HM10	HM11	HM12	HM13
1	Ampicillin	R	S	S	S	S	S	S	S	S	S	S
2	Imipenem	S	S	S	S	S	S	S	S	S	S	S
3	Meropenem	S	S	S	S	S	S	S	S	S	S	S
4	Methicillin	R	R	R	R	R	R	R	R	R	R	R
5	Oxacillin	R	R	R	R	R	R	R	R	R	R	R
6	Penicillin	R	S	15.3 ± 0.57	19 ± 0	S	17.6 ± 0.57	19 ± 1	S	16.3 ± 0.57	16.6 ± 0.57	S
7	Cefuroxime	17.6 ± 0.57	R	R	R	S	16.3 ± 0.57	R	16 ± 0	R	R	R
8	Cefoxitin	R	R	R	R	R	R	R	R	R	R	R
9	Ceftazidime	15.3 ± 0.57	R	R	R	18.3 ± 0.57	17.3 ± 0.57	16.3 ± 0.57	R	16.3 ± 0.57	16 ± 1	R
10	Cefotaxime	15.6 ± 0.57	S	S	S	S	S	S	S	S	S	S
11	Teicoplanin	R	R	R	R	R	R	R	R	R	R	R
12	Vancomycin	R	R	R	R	R	R	R	R	R	R	R
13	Ciprofloxacin	R	R	R	R	R	R	R	R	R	R	R
14	Ofloxacin	R	R	R	R	R	R	R	R	R	R	R
15	Gentamicin	17.3 ± 0.57	16.3 ± 0.57	16 ± 0	15.3 ± 0.57	16.6 ± 0.57	17.3 ± 0.57	17 ± 1	16.3 ± 0.57	15.6 ± 0.57	16.3 ± 0.57	R
16	Streptomycin	R	R	R	R	R	R	R	R	R	R	R
17	Tobramycin	R	R	R	R	R	R	R	R	R	R	R
18	Chloramphenicol	17.3 ± 0.57	S	S	S	S	S	S	S	S	S	S
19	Clindamycin	S	R	R	R	R	R	15.6 ± 0.57	R	R	16.3 ± 0.57	R
20	Erythromycin	17.6 ± 0.57	S	S	S	S	S	S	S	S	S	S
21	Fusidic acid	R	16.3 ± 0.57	17.3 ± 0.57	16.6 ± 0.57	17 ± 1	16.3 ± 0.57	R	17 ± 0	R	17.6 ± 0.57	15.6 ± 0.57
22	Nitrofurantoin	R	S	S	S	S	S	S	S	S	S	S
23	Tetracycline	19.3 ± 0.57	S	17.6 ± 0.57	18.3 ± 0.57	S	19 ± 0	17.3 ± 0.57	18.6 ± 0.57	16.3 ± 0.57	S	19 ± 0
24	Tigecycline	16.6 ± 0.57	S	S	S	S	S	S	S	S	S	S
25	Co-Trimoxazole	R	R	R	R	R	R	R	R	R	R	R
26	Trimethoprim	R	S	R	R	R	R	R	R	R	19 ± 0	18.3 ± 0.57